Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025)
Envoy Medical's (COCH) quarterly Amortization of Deferred Charges came in at $4000.0 in Q4 2025, down 98.96% year-on-year from $384000.0 in Q4 2024, and down 99.15% quarter-over-quarter from $468000.0 in Q3 2025.
Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Envoy Medical has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $4000.0 for Q4 2025.
- Amortization of Deferred Charges for Q4 2025 came in at $4000.0, down 98.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY), and the FY2025 annual result was $1.6 million, up 94.85% from the prior year.
- Amortization of Deferred Charges came in at $4000.0 for Q4 2025 at Envoy Medical, down from $468000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $623000.0 in Q2 2025 to a low of $4000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Envoy Medical | 44.81 Mn | 19.56 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 468,000.00 |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 623,000.00 |
| Jun 30, 2025 | 623,000.00 |
| Mar 31, 2025 | 495,000.00 |
| Mar 31, 2025 | 495,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |